DekaBank Deutsche Girozentrale lowered its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 61.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 213,148 shares of the pharmacy operator’s stock after selling 336,068 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Walgreens Boots Alliance were worth $11,776,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. LSV Asset Management boosted its stake in Walgreens Boots Alliance by 0.9% in the 1st quarter. LSV Asset Management now owns 11,672,531 shares of the pharmacy operator’s stock worth $738,521,000 after buying an additional 107,600 shares during the last quarter. Geode Capital Management LLC boosted its stake in Walgreens Boots Alliance by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock worth $786,522,000 after buying an additional 834,241 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec raised its holdings in shares of Walgreens Boots Alliance by 11.4% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 10,667,865 shares of the pharmacy operator’s stock worth $674,956,000 after purchasing an additional 1,093,610 shares during the period. Nordea Investment Management AB raised its holdings in shares of Walgreens Boots Alliance by 2.0% in the 1st quarter. Nordea Investment Management AB now owns 7,679,640 shares of the pharmacy operator’s stock worth $485,896,000 after purchasing an additional 148,814 shares during the period. Finally, The Manufacturers Life Insurance Company raised its holdings in shares of Walgreens Boots Alliance by 263.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 3,306,439 shares of the pharmacy operator’s stock worth $209,198,000 after purchasing an additional 2,396,640 shares during the period. 61.97% of the stock is currently owned by institutional investors and hedge funds.
A number of equities analysts have recently commented on WBA shares. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective on the stock. in a report on Monday, June 10th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, June 28th. Bank of America cut their price objective on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a report on Monday, June 3rd. JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a report on Friday, June 28th. Finally, Morgan Stanley set a $61.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Tuesday, May 14th. Six research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $63.82.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The firm had revenue of $34.59 billion during the quarter, compared to analyst estimates of $34.52 billion. During the same quarter last year, the firm earned $1.53 EPS. Walgreens Boots Alliance’s quarterly revenue was up .7% on a year-over-year basis. On average, analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th will be paid a dividend of $0.458 per share. This represents a $1.83 dividend on an annualized basis and a yield of 3.63%. The ex-dividend date of this dividend is Monday, August 19th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the firm’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the completion of the sale, the chief accounting officer now owns 357,851 shares in the company, valued at approximately $18,064,318.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 15.73% of the stock is owned by company insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Percentage Decliners
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.